Ashok Srinivasan MD
Assistant Professor, Pediatrics, University of Tennessee Health Science Center College of Medicine
Join to View Full Profile
262 Danny Thomas PlMemphis, TN 38105
Phone+1 901-595-3006
Fax+1 901-595-3842
Dr. Srinivasan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of TennesseeFellowship, Pediatric Infectious Diseases, 2006 - 2008
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Pediatric Hematology/Oncology, 1993 - 1996
Maulana Azad Medical CollegeClass of 1985
Certifications & Licensure
CA State Medical License 1993 - Present
TN State Medical License 2008 - 2025
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Hematology-Oncology
- American Board of Pediatrics Pediatric Infectious Diseases
Clinical Trials
- Dose Escalation Study Of Palifermin in Pediatric Research Participants Undergoing Allogeneic Hematopoietic Stem Cell Transplantation Start of enrollment: 2007 Sep 01
- A Pediatric Study of a Plerixafor Containing Regimen In Second Allogeneic Stem Cell Transplantation Start of enrollment: 2010 May 01
Publications & Presentations
PubMed
- Reduced toxicity conditioning for hematopoietic stem cell transplantation in children with Diamond-Blackfan anemia.Amr Qudeimat, Shruthi Suryaprakash, Renee Madden, Ashok Srinivasan, Marcin W Wlodarski
Haematologica. 2024-10-01 - 1 citationsMemory T-cell enriched haploidentical transplantation with NK cell addback results in promising long-term outcomes: a phase II trial.Swati Naik, Ying Li, Aimee C Talleur, Subodh Selukar, Emily Ashcraft
Journal of Hematology & Oncology. 2024-06-27 - Disease Status and Interval between Hematopoietic Cell Transplantations Predict Outcome of Pediatric Patients Who Undergo Subsequent Transplantation for Relapsed Hemat...Rebecca Epperly, Ying Li, Subodh Selukar, Emily Zeng, Renee Madden
Transplantation and Cellular Therapy. 2024-05-01
Journal Articles
- Selective T‐Cell Depletion Targeting CD45RA Reduces Viremia and Enhances Early T‐Cell Recovery Compared with CD3‐Targeted T‐Cell DepletionBrandon M Triplett, David R Shook, Ewelina Mamcarz, Randall T Hayden, Shane J Cross, Ashok Srinivasan, Transplant Infectious Disease
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
